Lynx1 Capital Management’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,253,183
| Closed | -$89.3M | – | 21 |
|
|
2024
Q1 | $89.3M | Sell |
2,253,183
-1,560,743
| -41% | -$61.9M | 23.01% | 1 |
|
|
2023
Q4 | $72.7M | Buy |
3,813,926
+1,409,312
| +59% | +$26.9M | 28.58% | 1 |
|
|
2023
Q3 | $27.5M | Sell |
2,404,614
-265,858
| -10% | -$3.04M | 18.21% | 2 |
|
|
2023
Q2 | $27.5M | Sell |
2,670,472
-465,701
| -15% | -$4.79M | 17.99% | 3 |
|
|
2023
Q1 | $24.2M | Buy |
3,136,173
+10,000
| +0.3% | +$77.2K | 20.18% | 1 |
|
|
2022
Q4 | $23M | Buy |
3,126,173
+69,753
| +2% | +$513K | 19.87% | 2 |
|
|
2022
Q3 | $22M | Buy |
3,056,420
+1,129,551
| +59% | +$8.13M | 19.85% | 2 |
|
|
2022
Q2 | $16.4M | Buy |
1,926,869
+442,176
| +30% | +$3.76M | 13.97% | 4 |
|
|
2022
Q1 | $13.3M | Buy |
1,484,693
+222,766
| +18% | +$2M | 12.37% | 3 |
|
|
2021
Q4 | $17.5M | Buy |
+1,261,927
| New | +$17.5M | 15.25% | 3 |
|